Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Remarks:
Type of genotoxicity: gene mutation
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1986
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
guideline study with acceptable restrictions

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1986
Report date:
1986

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
Deviations:
not specified
Principles of method if other than guideline:
Bibliography: Ames et al., Mut.Research. 31: 347-364, 1975
Appropriate positive controls included
GLP compliance:
yes
Type of assay:
bacterial reverse mutation assay

Test material

Constituent 1
Chemical structure
Reference substance name:
Carboxylic acids, di-, C4-6
EC Number:
271-678-5
EC Name:
Carboxylic acids, di-, C4-6
Cas Number:
68603-87-2
Molecular formula:
C5H8O4, C4H6O4, C6H10O4
IUPAC Name:
Carboxylic acids, C4-6 di-
Details on test material:
Sample idetification: AGS Mixture:
Adipic acid: 6-9%
Glutaic acid 30-35%
Succinic acid 8-11%
Nitric acid 0.5 - 3%
Lot: FIT-85-45,46,47; white solid powder
Specific details on test material used for the study:
test item: AGS-Mixture (Adipic acid: 6-9%; Glutaric acid 30-35%; Succinic acid 8-11%; Nitric acid 0.5 - 3%) used as 50% aqueous solution

Method

Target gene:
Histidine auxotrothy
Species / strainopen allclose all
Species / strain / cell type:
S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
Species / strain / cell type:
S. typhimurium TA 1538
Metabolic activation:
with and without
Metabolic activation system:
rat liver S9 mix obtained from Aroclor 1254-treated Sprague Dawley rats
Test concentrations with justification for top dose:
30, 100, 300, 1000, 3000 µg/plate
These dose levels were determined in a preliminary toxicity screen with 10, 167, 500, 1667 and 5000 µg/plate.
Vehicle / solvent:
water
Controls
Untreated negative controls:
yes
Negative solvent / vehicle controls:
yes
Remarks:
Water
Positive controls:
yes
Positive control substance:
other: Sodium acide, 9-aminoacridine, 2-nitrofluorene, 2-anthramine
Details on test system and experimental conditions:
plate incorporation assay
Evaluation criteria:
A positive result is defined as a reproducible, dose-related increase in the number of histidine-independent colonies with at least one dose point inducing a mutant frequency value that is two-fold the solvent control value.
Statistics:
Significance at the 95% conficence limits is determined by the program developed by Moore and Felton (1983).

Results and discussion

Test results
Species / strain:
other: all strains tested
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Remarks on result:
other: all strains/cell types tested

Any other information on results incl. tables

Bacterial toxicity was investigated in a pilot experiment; no relevant colonies at 5000 µg/plate; high dose for main experiment: 3000µg/plate. All solvent and positive controls showed the expected results.

The results of the test article, AGS Mixture, were negative in strains TA 1535, 1537, 98 and 100 of S. typhimurium with and without metabolic activation at all doses tested (highest dose: 3000 µg/plate).

In the initial assay, strain 1538 exhibited an increase in mutant frequency at the hghest dose (2.5 fold above the concommitant control) without metaboilic activation. Two subsequent retests failed to confirm the initial observation (see Table 1)

Overall the authors concluded that the test compound is not mutagenic in the Ames test.

Table 1: summary of results

 dose level (µg/plate)  S9 -mix ( + or -)  TA1535  TA1537  TA98  TA100  TA1538 (1.exp)  TA1538 (2. exp)  TA1538 (3.exp)
 water  -  14  13  28  141  14  12  12
 water  +  9  11  44  159  20  -  -
 sodium acide, 10  -  1107  -  -  1152 -  -  -
 9 -Aminoacridine, 150  -  -  1496  - -  -  -  -
 2 -Nitrofluorene, 5  -  -  -  486  -  507  446  551
 2 -Anthramine, 2.5  +  250  232  1544  1467  1436  -  -
 AGS mix, 30  -  17  12  26  150 13  6 12
 AGS mix, 100 - 13  10  24  133  15  8 12
 AGS mix, 300  -  16  12  24  144  15  5  9
 AGS mix, 1000  -  14  15  32  148  15  11  16
 AGS mix, 3000  -  17  14  42  140  35  21  11
 AGS mix, 30  +  10  10  38  119  18  -  -
 AGS mix, 100  +  11  10  42  188  25  -  -
 AGS mix, 300  +  8  13  34  190  13  -  -
 AGS mix, 1000  +  8  18  43  181  31  -  -
 AGS mix, 3000  +  11  14  42  197  30  -  -

AGS mixture was tested as 50% aqueous solution.

Applicant's summary and conclusion

Executive summary:

Mutagenic activity of dicarboxylic acid mixture (AGS-Mixture, 50%) was investigated in a study similar to OECD TG 471 in bacteria (Salmonella typhimurium strains TA98, TA100, TA1535, TA1537 and TA1538) with or without metabolic activator S9. Cytotoxicity was observed at 5000 µg/plate. Negative and positive controls were functional in all experiments (Barfknecht 1986, BASF 1990).

In the initial assay, strain TA1538 exhibited a dose related increase in mutant frequency that reached 2.5-fold the solvent control background value without metabolic activation. However, two subsequent retests failed to confirm the initial observation. All other tests were negative. The authors concluded that dicarboxylic acid mixture is not mutagenic in the 5 strains tested with and without metabolic activation at dose levels of 30, 100, 300, 1000 and 3000 µg/plate.